NF2 polyclonal, anti-human, mouse
€362.00
In stock
SKU
200156
Catalog Nr.: 200156
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Datasheet
Request Information
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Datasheet
Request Information
Protein Family: Receptors and Channels
Pathway and Disease: Cancers, Nervous and Sensory Systems
Description:
Merlin (NF2) acts as a membrane stabilizing protein and may inhibit PI3 kinase by binding to CENTG1. Defects in NF2 are the cause of neurofibromatosis 2 and schwannnomatosis (neuromas).
Alternate Names: Merlin, Moesin-ezrin-radixin-like protein, neurofibromin-2, Schwannomin, Schwannomerlin, NF2, SCH
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500
Accession No.: P35240
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human NF2.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 12.5% glycerol with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
Pathway and Disease: Cancers, Nervous and Sensory Systems
Description:
Merlin (NF2) acts as a membrane stabilizing protein and may inhibit PI3 kinase by binding to CENTG1. Defects in NF2 are the cause of neurofibromatosis 2 and schwannnomatosis (neuromas).
Alternate Names: Merlin, Moesin-ezrin-radixin-like protein, neurofibromin-2, Schwannomin, Schwannomerlin, NF2, SCH
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500
Accession No.: P35240
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human NF2.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 12.5% glycerol with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
| Is Featured? | No |
|---|
Write Your Own Review